Failure of current laboratory protocols to detect lot-to-lot reagent differences: Findings and possible solutions

Clinical Chemistry

Volumn 59, Issue 8, 2013, Pages 1187-1194

  Algeciras Schimnich, Alicia ^a   Bruns, David E ^b   Boyd, James C ^b   Bryant, Sandra C ^a   La Fortune, Kristin A ^b   Grebe, Stefan K G ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REAGENT;

ASSAY; GOOD LABORATORY PRACTICE; LABORATORY TEST; REVIEW; SAMPLE; VALIDATION STUDY;

HUMANS; INSULIN-LIKE GROWTH FACTOR I; LUMINESCENT MEASUREMENTS; QUALITY CONTROL; REAGENT KITS, DIAGNOSTIC; REFERENCE VALUES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84880911851     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.205070     Document Type: Review

References (18)

1. Martindale RA, Journault LJ, Crawford JL, Tran C, Hofer TL, Rintoul BJ, et al. Validating new reagents: roadmaps through the wilderness. Lab Med 2006;37:347-51.
2. Linnet K. Necessary sample size for method comparison studies based on regression analysis. Clin Chem 1999;45:882-94.
3. Mazzo DJ, Connolly M. Analytical method comparison based upon statistical power calculations. Pharm Res 1992;9:601-6.
4. Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, et al. A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 2010;95:3141-8.
5. Cook DM, Yuen KC, Biller BM, Kemp SF, Vance ML. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormonedeficient adults and transition patients-2009 update. Endocr Pract 2009;15(Suppl 2):1-29.
6. Cook DM, Yuen KC, Biller BM, Kemp SF, Vance ML. American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormonedeficient adults and transition patients-2009 update: executive summary of recommendations. Endocr Pract 2009;15:580-6.
7. Elmlinger MW, Kuhnel W, Weber MM, Ranke MB. Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin Chem Lab Med 2004;42:654-64.
8. Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using g. power 3.1: tests for correlation and regression analyses. Behav Res Methods 2009;41:1149-60.
9. Siemens Healthcare Diagnostics. IMMULITE®, IMMULITE® 1000, IMMULITE® 2000, IMMULITE® 2000 XPi: All Immulite platforms for IGF-1 shift in patient medians and supply disruption. http://www.mhra.gov.uk/home/ groups/fsn/documents/fieldsafetynotice/con207161.pdf (Accessed June 2013). Urgent field safety notice no. 4005.
10. Carey RN, Frye RM, Cook JD, Koch TR, Harris EK. Between-lot/between- instrument variations of the Abbott IMX method for prostate-specific antigen. Clin Chem 1992;38:2341-3.
11. Dufour DR. Lot-to-lot variation in anti-hepatitis C signal-to-cutoff ratio. Clin Chem 2004;50:958-60.
12. Goodman DB, Bulley M, Hendricks M, Senior M. Assessment of the Abbott IMX assay system for the measurement of human chorionic gonadotropin levels in the treatment of ectopic pregnancy. Arch Pathol Lab Med 1993;117:701-3.
13. Wener MH, Daum PR, Brawer MK. Variation in measurement of prostate-specific antigen: importance of method and lot variability. Clin Chem 1995;41:1730-7.
14. Miller WG, Erek A, Cunningham TD, Oladipo O, Scott MG, Johnson RE. Commutability limitations influence quality control results with different reagent lots. Clin Chem 2011;57:76-83.
15. Bull BS, Korpman BA. Intralaboratory quality control using patient's data. In: Covill I, editor. Quality control (methods in hematology). New York: Churchill Livingstone: 1982, p. 121-150.
16. Cembrowski GS, Westgard JO. Quality control of multichannel hematology analyzers: evaluation of Bull's algorithm. Am J Clin Pathol 1985;83:337-45.
17. Wilson A, Roberts WL, Pavlov I, Fontenot J, Jackson B. Patient result median monitoring for clinical laboratory quality control. Clin Chim Acta 2011;412:1441-6.
18. Bystrom CE, Sheng S, Clarke NJ. Narrow mass extraction of time-of-flight data for quantitative analysis of proteins: determination of insulin-like growth factor-1. Anal Chem 2011;83:9005-10.